about
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastomaBrain tumors in Sweden: data from a population-based registry 1999-2012.Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.[Survival in malignant gliomas has increased the last decade. Analysis of quality data].Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study.Considerable improvement in survival for patients aged 60-84 years with high grade malignant gliomas -- data from the Swedish Brain Tumour Population-based Registry.MTR-09ABCB1 AS PREDICTIVE MARKER FOR POOR SURVIVAL IN PATIENTS WITH GLIOBLASTOMA TREATED WITH RADIOTHERAPY AND CONCOMITANT AND ADJUVANT TEMOZOLOMIDE.Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial.Long-term follow-up of acupuncture and hormone therapy on hot flushes in women with breast cancer: a prospective, randomized, controlled multicenter trial.High-grade astrocytoma treated concomitantly with estramustine and radiotherapy.Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: novel treatment predictive factors identified.[Registration on regional basis of patients with primary brain tumors. Regional differences disclosed].Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levelsTreatment options in elderly patients with glioblastoma – Authors' replyABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomideThe Genetic Architecture of Gliomagenesis-Genetic Risk Variants Linked to Specific Molecular Subtypes
P50
Q28390726-729555C0-DAB9-468D-AA1F-8638236118EFQ30868551-66246452-77DF-4AEA-902F-65C288C52EB5Q33402747-A73126C1-8FF8-418D-9C76-BC07C62AF50FQ34284985-5E8F5FA7-8ACB-43E5-B1A5-030B4E3B1CD2Q35787908-6835F057-1188-4A1D-BD81-0C7E47AEC06DQ37687232-723E1ED8-3A6E-40A1-8E7C-CD9FA04180BDQ38675705-D6707B69-652E-4169-B0AE-EF22F439BE5EQ43258971-90594BFF-9634-4CC7-94A6-323082FA94EAQ44424242-0D5F990D-6B49-4FBC-B258-C5ADB773F821Q45833652-B48F1A8D-30E5-4B70-AD6A-05351C4FCF10Q48181947-CD7F9008-2152-43B7-B13B-862C2E2E4BE5Q48505898-A7E85CBD-DF68-40B0-9955-49F18CA7ECDFQ48591773-CAE60768-57D5-48A4-B9F6-B9CE8A431150Q50508373-3A921395-B52A-44F6-B61C-3DEB90D46936Q55468446-006D0DA2-FEA4-4B03-9489-8A48F397BF85Q61054478-C9F9B2F2-FFB2-4636-B785-60E89974AEAEQ61124442-9DFC6D8F-65CB-47B6-9674-88ACDEE85BECQ90781971-F57372FC-E537-48E0-A528-BB3364FF59BEQ92012397-AA007734-D709-4C89-ADA9-BFEE6DAACEDE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Annika Malmström
@ast
Annika Malmström
@en
Annika Malmström
@es
Annika Malmström
@nl
type
label
Annika Malmström
@ast
Annika Malmström
@en
Annika Malmström
@es
Annika Malmström
@nl
prefLabel
Annika Malmström
@ast
Annika Malmström
@en
Annika Malmström
@es
Annika Malmström
@nl
P106
P1153
19735626400
P21
P31
P496
0000-0001-8410-4939